Effect of prolonged beta-adrenergic blockade induced by atenolol on left ventricular remodeling after acute myocardial infarction in the rat.

Beta-adrenergic receptor blockade reduces the mortality rate after acute myocardial infarction (AMI) in humans. However, the effects of beta blockade on left ventricular remodeling remain unknown. Therefore, in the present study we investigated the effect of prolonged beta-adrenergic receptor blockade with atenolol on left ventricular remodeling following AMI in rats. Myocardial infarction (MI) was produced in Wistar-Kyoto rats by ligating the coronary artery. Four groups of rats were studied: sham-operated (n = 10); atenolol (1 g/l in drinking water) treated sham-operated (n = 8); untreated MI (n = 11); atenolol treated MI (n = 10). Hemodynamic measurements were made about 3 weeks after the operation. Infarct size was similar in treated and untreated MI rats (31.2 +/- 2.5% cf. 33.5 +/- 2.0%). MI rats were characterized by increases in left ventricular end-diastolic pressure (LVEDP), right atrial pressure (RAP), right ventricular systolic pressure (RVSP), and left ventricular end-diastolic volume index (LVEDVI), as compared with sham-operated rats. In sham-operated rats, prolonged beta-adrenergic receptor blockade produced only a reduced HR. Atenolol-treated MI rats had a significantly higher LVEDP, RAP and LVEDVI than did rats with untreated MI. Prolonged beta-adrenergic receptor blockade with atenolol appeared to promote left ventricular remodeling after AMI. Thus, the treatment of AMI with beta-adrenergic receptor blockade in the clinical setting should be evaluated with respect to ventricular remodeling during prolonged therapy.

[1]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[2]  Eric J. Topol,et al.  A Randomized Trial of Late Reperfusion Therapy for Acute Myocardial Infarction , 1992, Circulation.

[3]  E. Frohlich,et al.  Effects of alpha 1-adrenergic blockade on intrarenal hemodynamics in heart failure rats. , 1992, The American journal of physiology.

[4]  J. Hochman,et al.  Effect of atenolol on myocardial infarct expansion in a nonreperfused rat model. , 1991, American heart journal.

[5]  E. Sonnenblick,et al.  Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. , 1991, Circulation research.

[6]  D. Bonaduce,et al.  Effects of late administration of tissue-type plasminogen activator on left ventricular remodeling and function after myocardial infarction. , 1990, Journal of the American College of Cardiology.

[7]  S. Goldman,et al.  Chronic Propranolol Treatment Promotes Left Ventricular Dilation Without Altering Systolic Function After Large Myocardial Infarction in Rats , 1990, Journal of cardiovascular pharmacology.

[8]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[9]  P. Marino,et al.  Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. , 1989, Journal of the American College of Cardiology.

[10]  E. Braunwald,et al.  Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? , 1989, Circulation.

[11]  N. Trippodo,et al.  Increased ANF secretion after volume expansion is preserved in rats with heart failure. , 1988, The American journal of physiology.

[12]  J. Hochman,et al.  Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. , 1987, Circulation.

[13]  W Grossman,et al.  Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. , 1986, Circulation.

[14]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[15]  Johan Herlitz,et al.  Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group. , 1985, European heart journal.

[16]  P. Molinoff,et al.  Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. , 1983, The Journal of pharmacology and experimental therapeutics.

[17]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[18]  M. Pfeffer,et al.  Left Ventricular Diastolic Pressure‐Volume Relations in Rats with Healed Myocardial Infarction: Effects on Systolic Function , 1981, Circulation research.

[19]  A. L. Simon,et al.  Left Ventricular Size after Acute Myocardial Infarction: Serial Changes and their Prognostic Significance , 1973, Circulation.

[20]  J. Covell,et al.  Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions , 1971, Circulation.

[21]  H. Selye,et al.  Simple Techniques for the Surgical Occlusion of Coronary Vessels in the Rat , 1960, Angiology.

[22]  T N P JOHNS,et al.  EXPERIMENTAL MYOCARDIAL INFARCTION. I. A. METHOD OF CORONARY OCCLUSION IN SMALL ANIMALS , 1954, Annals of surgery.